PATENT CLAIM ANALYSIS

Application Number: 15918788
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "185100"]

Abstract:
A method of eliciting an immune response in a patient who has a cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize the cancer cells in the patient that aberrantly express a peptide consisting of the amino acid sequence of GVYDGEEHSV (SEQ ID NO: 303), in which the peptide is in a complex with an MHC molecule.

Claim (Index 18):
The method of  claim 17 , wherein the T cell response is a cytotoxic T cell response.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.42
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15917159', '15362294', '15789731', '15083075', '15638687']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7561593558353957
- 35 USC 102 Novelty (BERT): 0.5246817536726749
- Combined Prediction Score: 0.7330115956191237
- Mean Citation Score: 326.151742
- Max Citation Score: 327.15237
- Similarity Product: 234.1433901261163

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test